132 related articles for article (PubMed ID: 8088382)
1. Treatment of hypogammaglobulinaemia in chronic lymphocytic leukaemia by low-dose intravenous gammaglobulin.
Jurlander J; Geisler CH; Hansen MM
Eur J Haematol; 1994 Aug; 53(2):114-8. PubMed ID: 8088382
[TBL] [Abstract][Full Text] [Related]
2. [Correlations between secondary hypogammaglobulinaemia, infections and mortality and the need for preventive immunoglobulin replacement in patients with chronic lymphoid leukaemia].
Losonczy H; Nagy Á; Kosztolányi S; Tóth O; Csalódi R; Hussain A; Szomor Á
Orv Hetil; 2019 Sep; 160(38):1487-1494. PubMed ID: 31537095
[TBL] [Abstract][Full Text] [Related]
3. Randomized trial of intravenous immunoglobulin prophylaxis for patients with chronic lymphocytic leukaemia and secondary hypogammaglobulinaemia.
Boughton BJ; Jackson N; Lim S; Smith N
Clin Lab Haematol; 1995 Mar; 17(1):75-80. PubMed ID: 7621634
[TBL] [Abstract][Full Text] [Related]
4. Intravenous immune globulin in chronic lymphocytic leukaemia.
Gamm H; Huber C; Chapel H; Lee M; Ries F; Dicato MA
Clin Exp Immunol; 1994 Jul; 97 Suppl 1(Suppl 1):17-20. PubMed ID: 8033428
[TBL] [Abstract][Full Text] [Related]
5. Effect of various doses of intravenous polyclonal IgG on in vivo levels of 12 pneumococcal antibodies in patients with chronic lymphocytic leukaemia and multiple myeloma.
Sklenar I; Schiffman G; Jønsson V; Verhoef G; Birgens H; Boogaerts M; Ferrant A; Christensen BE; Hasle H; Drivsholm A
Oncology; 1993; 50(6):466-77. PubMed ID: 8233289
[TBL] [Abstract][Full Text] [Related]
6. Immunoglobulin replacement therapy in chronic lymphocytic leukaemia patients with hypogammaglobulinaemia and infection.
Keegan A; Dennington PM; Dhondy N; Mulligan SP
Eur J Haematol; 2022 Jun; 108(6):460-468. PubMed ID: 35152500
[TBL] [Abstract][Full Text] [Related]
7. The clinical significance of hypogammaglobulinaemia and serum immunoglobulin G subclass deficiency in patients with chronic lymphocytic leukaemia (CLL).
Best OG; Crassini K; Freeman JA; Mulligan SP;
Scand J Infect Dis; 2013 Sep; 45(9):729. PubMed ID: 23826794
[No Abstract] [Full Text] [Related]
8. Case 22-2005: intravenous immune globulin in chronic lymphocytic leukemia.
Newcom SR
N Engl J Med; 2005 Oct; 353(17):1862-3; author reply 1862-3. PubMed ID: 16251548
[No Abstract] [Full Text] [Related]
9. Clinical significance of serum immunoglobulin G subclass deficiency in patients with chronic lymphocytic leukemia.
Svensson T; Höglund M; Cherif H
Scand J Infect Dis; 2013 Jul; 45(7):537-42. PubMed ID: 23427875
[TBL] [Abstract][Full Text] [Related]
10. Serial Serum Immunoglobulin G (IgG) Trough Levels in Patients with X-linked Agammaglobulinemia on Replacement Therapy with Intravenous Immunoglobulin: Its Correlation with Infections in Indian Children.
Suri D; Bhattad S; Sharma A; Gupta A; Rawat A; Sehgal S; Singh S; Gupta S
J Clin Immunol; 2017 Apr; 37(3):311-318. PubMed ID: 28321612
[TBL] [Abstract][Full Text] [Related]
11. Prophylaxis against infections with low-dose intravenous immunoglobulins (IVIG) in chronic lymphocytic leukemia. Results of a crossover study.
Molica S; Musto P; Chiurazzi F; Specchia G; Brugiatelli M; Cicoira L; Levato D; Nobile F; Carotenuto M; Liso V; Rotoli B
Haematologica; 1996; 81(2):121-6. PubMed ID: 8641639
[TBL] [Abstract][Full Text] [Related]
12. Crossover study of immunoglobulin replacement therapy in patients with low-grade B-cell tumors.
Griffiths H; Brennan V; Lea J; Bunch C; Lee M; Chapel H
Blood; 1989 Feb; 73(2):366-8. PubMed ID: 2492832
[TBL] [Abstract][Full Text] [Related]
13. Intravenous gammaglobulin treatment in patients with hypogammaglobulinaemia.
So A; Brenner MK; Hill ID; Asherson GL; Webster AD
Br Med J (Clin Res Ed); 1984 Nov; 289(6453):1177-8. PubMed ID: 6437475
[TBL] [Abstract][Full Text] [Related]
14. Immunoglobulin replacement in chronic lymphocytic leukaemia.
Bunch C
Nouv Rev Fr Hematol (1978); 1988; 30(5-6):419-22. PubMed ID: 3065737
[TBL] [Abstract][Full Text] [Related]
15. Immunoglobulin replacement in patients with chronic lymphocytic leukemia (CLL): kinetics of immunoglobulin metabolism.
Chapel HM; Lee M
J Clin Immunol; 1992 Jan; 12(1):17-20. PubMed ID: 1551938
[TBL] [Abstract][Full Text] [Related]
16. Hypogammaglobulinaemia in low grade B cell tumours; significance and therapy.
Chapel H; Griffiths H; Brennan V; Bunch C; Lea J; Lee M
Immunol Invest; 1991 Apr; 20(2):187-91. PubMed ID: 1864637
[TBL] [Abstract][Full Text] [Related]
17. High- vs low-dose immunoglobulin therapy in the long-term treatment of X-linked agammaglobulinemia.
Liese JG; Wintergerst U; Tympner KD; Belohradsky BH
Am J Dis Child; 1992 Mar; 146(3):335-9. PubMed ID: 1543181
[TBL] [Abstract][Full Text] [Related]
18. Disease activity and pretreatment, rather than hypogammaglobulinaemia, are major risk factors for infectious complications in patients with chronic lymphocytic leukaemia.
Hensel M; Kornacker M; Yammeni S; Egerer G; Ho AD
Br J Haematol; 2003 Aug; 122(4):600-6. PubMed ID: 12899715
[TBL] [Abstract][Full Text] [Related]
19. An evaluation of the safety of three intravenous immunoglobulin preparations in patients with primary hypogammaglobulinaemia.
Yap PL; McClelland DB
J Infect; 1986 Jan; 12(1):5-10. PubMed ID: 3082994
[TBL] [Abstract][Full Text] [Related]
20. Should treatment of hypogammaglobulinemia with immunoglobulin replacement therapy (IgRT) become standard of care in patients with chronic lymphocytic leukemia?
Noto A; Cassin R; Mattiello V; Bortolotti M; Reda G; Barcellini W
Front Immunol; 2023; 14():1062376. PubMed ID: 37122737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
